Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₩52,200, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 103% over the past three years. Annonce • Feb 28
WONIK Materials Co.,Ltd., Annual General Meeting, Mar 26, 2026 WONIK Materials Co.,Ltd., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 30, yangcheong 3-gil, ochang-eup, cheongwon-gu, chungcheongbuk-do, cheongju South Korea Annonce • Feb 20
WONIK Materials Co.,Ltd. to Report Q4, 2025 Results on Feb 26, 2026 WONIK Materials Co.,Ltd. announced that they will report Q4, 2025 results on Feb 26, 2026 Valuation Update With 7 Day Price Move • Jan 26
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩37,600, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 32% over the past three years. Price Target Changed • Dec 31
Price target increased by 21% to ₩43,333 Up from ₩35,667, the current price target is an average from 3 analysts. New target price is 40% above last closing price of ₩30,900. Stock is up 79% over the past year. The company is forecast to post earnings per share of ₩3,298 for next year compared to ₩2,523 last year. Upcoming Dividend • Dec 22
Upcoming dividend of ₩350 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 22 April 2026. Payout ratio is a comfortable 13% but the company is not cash flow positive. Trailing yield: 1.2%. Lower than top quartile of South Korean dividend payers (3.6%). In line with average of industry peers (1.3%). New Risk • Nov 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.0% average weekly change). Reported Earnings • Nov 19
Third quarter 2025 earnings: EPS and revenues exceed analyst expectations Third quarter 2025 results: EPS: ₩994 (up from ₩724 in 3Q 2024). Revenue: ₩82.8b (up 4.4% from 3Q 2024). Net income: ₩12.5b (up 37% from 3Q 2024). Profit margin: 15% (up from 12% in 3Q 2024). Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) also surpassed analyst estimates by 66%. Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Declared Dividend • Nov 08
Dividend of ₩350 announced Dividend of ₩350 is the same as last year. Ex-date: 29th December 2025 Payment date: 22nd April 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (14% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 9.8% per year over the past 6 years. However, payments have been volatile during that time. EPS is expected to grow by 69% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annonce • Nov 07
WONIK Materials Co.,Ltd. announces Annual dividend, payable on April 22, 2026 WONIK Materials Co.,Ltd. announced Annual dividend of KRW 350.0000 per share payable on April 22, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Price Target Changed • Sep 23
Price target increased by 16% to ₩35,667 Up from ₩30,667, the current price target is an average from 3 analysts. New target price is 12% above last closing price of ₩31,850. Stock is up 23% over the past year. The company is forecast to post earnings per share of ₩3,047 for next year compared to ₩2,523 last year. Valuation Update With 7 Day Price Move • Sep 22
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩30,800, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩17,835 per share. Major Estimate Revision • Aug 29
Consensus EPS estimates increase by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from ₩306.7m to ₩311.0m. EPS estimate increased from ₩2,727 to ₩3,015 per share. Net income forecast to grow 44% next year vs 37% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩30,333 unchanged from last update. Share price rose 4.1% to ₩24,050 over the past week. New Risk • Aug 28
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Major Estimate Revision • Aug 09
Consensus EPS estimates fall by 20% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩320.1m to ₩306.7m. EPS estimate also fell from ₩3,409 per share to ₩2,727 per share. Net income forecast to grow 9.0% next year vs 48% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩30,333. Share price was steady at ₩22,700 over the past week. Reported Earnings • Mar 22
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: ₩2,523 (up from ₩1,098 in FY 2023). Revenue: ₩310.7b (down 21% from FY 2023). Net income: ₩31.8b (up 130% from FY 2023). Profit margin: 10% (up from 3.5% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 16%. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings. Major Estimate Revision • Mar 15
Consensus EPS estimates fall by 12% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩338.4m to ₩331.1m. EPS estimate also fell from ₩3,529 per share to ₩3,120 per share. Net income forecast to grow 36% next year vs 27% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩29,500. Share price rose 9.2% to ₩21,200 over the past week. Annonce • Feb 26
WONIK Materials Co.,Ltd., Annual General Meeting, Mar 26, 2025 WONIK Materials Co.,Ltd., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 30, yangcheong 3-gil, ochang-eup, cheongwon-gu, chungcheongbuk-do, cheongju South Korea Annonce • Feb 19
WONIK Materials Co.,Ltd. to Report Q4, 2024 Results on Feb 25, 2025 WONIK Materials Co.,Ltd. announced that they will report Q4, 2024 results on Feb 25, 2025 Valuation Update With 7 Day Price Move • Feb 19
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩22,900, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 35% over the past three years. Price Target Changed • Dec 27
Price target decreased by 21% to ₩29,000 Down from ₩36,667, the current price target is an average from 2 analysts. New target price is 67% above last closing price of ₩17,320. Stock is down 42% over the past year. The company is forecast to post earnings per share of ₩2,987 for next year compared to ₩1,098 last year. Upcoming Dividend • Dec 20
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 23 April 2025. Payout ratio is a comfortable 6.6% and this is well supported by cash flows. Trailing yield: 0.9%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%). Price Target Changed • Nov 20
Price target decreased by 7.6% to ₩36,667 Down from ₩39,667, the current price target is an average from 3 analysts. New target price is 109% above last closing price of ₩17,550. Stock is down 36% over the past year. The company is forecast to post earnings per share of ₩2,931 for next year compared to ₩1,098 last year. Valuation Update With 7 Day Price Move • Nov 14
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩17,370, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total loss to shareholders of 43% over the past three years. Major Estimate Revision • Nov 12
Consensus EPS estimates fall by 25% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩332.3m to ₩313.5m. EPS estimate also fell from ₩3,909 per share to ₩2,946 per share. Net income forecast to grow 95% next year vs 38% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩39,667 to ₩38,333. Share price fell 12% to ₩18,430 over the past week. Price Target Changed • Sep 07
Price target decreased by 8.8% to ₩41,667 Down from ₩45,667, the current price target is an average from 3 analysts. New target price is 59% above last closing price of ₩26,150. Stock is up 1.8% over the past year. The company is forecast to post earnings per share of ₩3,949 for next year compared to ₩1,098 last year. Major Estimate Revision • Aug 31
Consensus EPS estimates increase by 14% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from ₩311.8m to ₩326.6m. EPS estimate increased from ₩3,302 to ₩3,772 per share. Net income forecast to grow 120% next year vs 64% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩45,667 unchanged from last update. Share price was steady at ₩28,700 over the past week. Price Target Changed • Aug 24
Price target increased by 14% to ₩45,667 Up from ₩40,000, the current price target is an average from 3 analysts. New target price is 59% above last closing price of ₩28,750. Stock is up 11% over the past year. The company is forecast to post earnings per share of ₩3,302 for next year compared to ₩1,098 last year. Major Estimate Revision • Aug 10
Consensus revenue estimates decrease by 14%, EPS upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from ₩361.0m to ₩311.8m. EPS estimate increased from ₩3,041 to ₩3,302 per share. Net income forecast to grow 215% next year vs 33% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩40,000 to ₩41,000. Share price rose 2.5% to ₩30,400 over the past week. Reported Earnings • Mar 23
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2023 results: EPS: ₩1,098 (down from ₩4,579 in FY 2022). Revenue: ₩391.7b (down 33% from FY 2022). Net income: ₩13.8b (down 76% from FY 2022). Profit margin: 3.5% (down from 9.9% in FY 2022). Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates by 37%. Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Dec 20
Upcoming dividend of ₩800 per share at 2.6% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%). Price Target Changed • Sep 19
Price target decreased by 7.9% to ₩35,000 Down from ₩38,000, the current price target is an average from 2 analysts. New target price is 28% above last closing price of ₩27,300. Stock is down 1.6% over the past year. The company is forecast to post earnings per share of ₩1,282 for next year compared to ₩4,579 last year. Major Estimate Revision • May 09
Consensus EPS estimates fall by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩517.3m to ₩499.5m. EPS estimate also fell from ₩4,488 per share to ₩3,986 per share. Net income forecast to shrink 20% next year vs 33% growth forecast for Chemicals industry in South Korea . Consensus price target down from ₩38,000 to ₩37,000. Share price rose 3.8% to ₩27,250 over the past week. Buying Opportunity • Mar 31
Now 21% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be ₩35,872, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 10% in 2 years. Earnings is forecast to grow by 54% in the next 2 years. Reported Earnings • Mar 26
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: EPS: ₩4,579 (up from ₩4,188 in FY 2021). Revenue: ₩581.3b (up 87% from FY 2021). Net income: ₩57.7b (up 9.3% from FY 2021). Profit margin: 9.9% (down from 17% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Mar 02
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 12%. The fair value is estimated to be ₩35,222, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 38% in the next 2 years. Upcoming Dividend • Dec 21
Upcoming dividend of ₩400 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 27 April 2023. Payout ratio is a comfortable 8.1% but the company is not cash flow positive. Trailing yield: 1.4%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Buying Opportunity • Dec 15
Now 22% undervalued Over the last 90 days, the stock is up 10%. The fair value is estimated to be ₩39,038, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 38% in the next 2 years. Reported Earnings • Nov 20
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Third quarter 2022 results: EPS: ₩1,670 (up from ₩1,043 in 3Q 2021). Revenue: ₩153.9b (up 94% from 3Q 2021). Net income: ₩21.0b (up 60% from 3Q 2021). Profit margin: 14% (down from 17% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.8%. Earnings per share (EPS) also surpassed analyst estimates by 38%. Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Price Target Changed • Nov 20
Price target decreased to ₩39,000 Down from ₩45,333, the current price target is an average from 2 analysts. New target price is 23% above last closing price of ₩31,750. Stock is down 3.3% over the past year. The company is forecast to post earnings per share of ₩6,115 for next year compared to ₩4,188 last year. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). External Director Hye-Sung Park was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Price Target Changed • Aug 13
Price target decreased to ₩48,000 Down from ₩52,000, the current price target is an average from 3 analysts. New target price is 47% above last closing price of ₩32,750. Stock is down 0.5% over the past year. The company is forecast to post earnings per share of ₩5,750 for next year compared to ₩4,188 last year. Major Estimate Revision • Aug 12
Consensus revenue estimates increase by 21% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from ₩450.4m to ₩545.0m. EPS estimate increased from ₩5,008 to ₩5,494 per share. Net income forecast to grow 20% next year vs 11% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩52,000 to ₩48,667. Share price was steady at ₩32,750 over the past week. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩32,350, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 65% over the past three years. Major Estimate Revision • May 05
Consensus revenue estimates increase by 24% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from ₩379.1m to ₩470.4m. EPS estimate increased from ₩4,177 to ₩4,953 per share. Net income forecast to grow 18% next year vs 5.4% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩51,333. Share price rose 6.5% to ₩39,400 over the past week. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). External Director Hye-Sung Park was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Upcoming Dividend • Dec 22
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 4.4% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%). Major Estimate Revision • Nov 26
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 EPS estimate increased from ₩3,898 to ₩4,294. Revenue forecast steady at ₩303.6m. Net income forecast to shrink 9.1% next year vs 29% growth forecast for Chemicals industry in South Korea . Consensus price target of ₩49,333 unchanged from last update. Share price fell 2.3% to ₩32,100 over the past week. Major Estimate Revision • Aug 13
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 revenue forecast fell from ₩312.4m to ₩304.2m. EPS estimate rose from ₩3,563 to ₩4,058. Net income forecast to grow 41% next year vs 71% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩50,000 unchanged from last update. Share price fell 5.9% to ₩32,900 over the past week. Price Target Changed • Apr 25
Price target increased to ₩50,000 Up from ₩42,667, the current price target is an average from 3 analysts. New target price is 22% above last closing price of ₩41,150. Stock is up 82% over the past year. Reported Earnings • Mar 20
Full year 2020 earnings released: EPS ₩2,628 (vs ₩2,229 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: ₩276.8b (up 25% from FY 2019). Net income: ₩33.1b (up 18% from FY 2019). Profit margin: 12% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 8% per year. Is New 90 Day High Low • Mar 16
New 90-day high: ₩37,250 The company is up 10.0% from a price of ₩33,950 on 16 December 2020. Outperformed the South Korean market which is up 9.0% over the last 90 days. Lagged the Chemicals industry, which is up 17% over the same period. Simply Wall St's valuation model estimates the intrinsic value at ₩48,271 per share. Annonce • Feb 25
WONIK Materials Co.,Ltd., Annual General Meeting, Mar 24, 2021 WONIK Materials Co.,Ltd., Annual General Meeting, Mar 24, 2021, at 10:00 Korea Standard Time. Location: 3F, Gwahaksanup3ro 112, Ochang-ep, Cheongwon-ru, Cheongjusi South Korea Agenda: To approve the financial statements for 15th term; to amend the article of incorporation; to appoint directors; to appoint internal auditor; to approve the limit on remuneration of internal auditor; and to discuss other matters. Price Target Changed • Feb 03
Price target raised to ₩39,250 Up from ₩36,500, the current price target is an average from 3 analysts. The new target price is 12% above the current share price of ₩35,150. As of last close, the stock is up 32% over the past year. Is New 90 Day High Low • Jan 04
New 90-day high: ₩36,750 The company is up 32% from its price of ₩27,800 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩56,482 per share. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩150 Per Share Will be paid on the 21st of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.4% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.9%). Is New 90 Day High Low • Dec 15
New 90-day high: ₩33,300 The company is up 24% from its price of ₩26,800 on 16 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩56,606 per share. Price Target Changed • Nov 25
Price target raised to ₩35,500 Up from ₩32,700, the current price target is an average from 3 analysts. The new target price is 10% above the current share price of ₩32,200. As of last close, the stock is up 27% over the past year. Is New 90 Day High Low • Nov 16
New 90-day high: ₩29,450 The company is up 14% from its price of ₩25,900 on 18 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩49,528 per share. Is New 90 Day High Low • Oct 27
New 90-day low: ₩24,100 The company is down 16% from its price of ₩28,700 on 29 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩53,704 per share. Major Estimate Revision • Oct 17
Analysts update estimates The 2020 consensus revenue estimate increased from ₩258.6m to ₩273.0m. Earnings per share (EPS) estimate was lowered from ₩2,669 to ₩2,288 for the same period. Net income is expected to grow by 40% next year compared to 40% growth forecast for the Chemicals industry in South Korea. The consensus price target of ₩32,250 was unchanged from the last update. Share price is down by 6.8% to ₩26,100 over the past week.